Skip to main content

Medmira Inc(MIR-X)
TSX Venture

Today's Change
Delayed Last Update

Medmira Inc

155 Chain Lake Drive
Suite 1
Halifax NS B3S 1B3 CAN
P: 902-450-1588
F: 902-450-1580
https://www.medmira.com

Sectors & Indices

Sector
Industry
Employees

    Profile

    MedMira Inc is a biotechnology company engaged in the research, development, and manufacturing of rapid diagnostics and technologies. The company operates in one reportable operating segment, rapid diagnostic products and services. Its product line includes HIV, COVID-19, syphilis, Multiplex, Miriad RVF Toolkit, and H. pylori. The company generates revenue from North America, Europe, and other regions, with the majority generated from North America.

    Key Executives

    NameTitle
    Hermes ChanCEO/Co-Founder/Director
    Markus MeileCFO

    More from The Globe

    Bullish on FirstEnergy Corp.
    Monica Rizk
    The most oversold and overbought stocks on the TSX
    The Bay Street Financial District is shown with the Canadian flag in Toronto on Friday, August 5, 2022.
    Monday’s analyst upgrades and downgrades
    A Dollarama store is seen Tuesday, June 11, 2013 in Montreal. Dollarama Inc. raised its quarterly dividend by 10 per cent as it reported its fourth-quarter profit and sales rose compared with a year ago. THE CANADIAN PRESS/Paul Chiasson
    opinion
    Why are Canadian bank valuations so low?
    Tom Bradley
    number cruncher
    Eleven U.S. semiconductor stocks showing strength
    For Number Cruncher column in Globe Investor/ROB only.
    Wednesday’s analyst upgrades and downgrades
    An office building for Goeasy Ltd, a personal lender for subprime borrowers, in Mississauga, Ontario, on March 10, 2026.
    Bullish on Archer-Daniels-Midland Co.
    Monica Rizk
    Constellation ‘well-positioned’ to tackle AI disruption in software industry, company president says
    In this photo illustration, a mobile phone with the logo of Canadian company Constellation Software Inc. is seen in front of business website.

    All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

    Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

    Financial data provided by Zacks Investment Research.